Results 231 to 240 of about 351,718 (359)

Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion [PDF]

, 1982
HG Braine, LL Sensenbrenner, SK Wright, PJ Tutschka, R Saral, GW Santos   +5 more
openalex   +1 more source

Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement [PDF]

, 1985
N. K. C. Ramsay, Tucker W. LeBien, Mark Nesbit, P McGlave, Daniel Weisdorf, P Kenyon, DD Hurd, A Goldman, Tae Hee Kim, J Kersey   +9 more
openalex   +1 more source

Outcomes of Post‐Transplant Rh‐GCSF and Decitabine Maintenance Therapy in Patients With High‐Risk Myeloid Neoplasm

American Journal of Hematology, EarlyView.
Mathias Palmer, Anmol Baranwal, Rami Basmaci, Khalil Hassan, Jade Kutzke, Gabriel Bartoo, Hemant Murthy, James Foran, Abhishek A. Mangaonkar, Mehrdad Hefazi, Aasiya Matin, William J. Hogan, Mark Litzow, Mithun Vinod Shah, Hassan B. Alkhateeb   +14 more
wiley   +1 more source

Expert Perspective: Diagnosis and Treatment of Castleman Disease

Arthritis &Rheumatology, Accepted Article.
Summary Castleman disease (CD) is a major diagnostic challenge for Rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y.C. Chen, Lu Zhang, David C. Fajgenbaum   +2 more
wiley   +1 more source

Bone marrow transplantation reverses metabolic alterations in multiple sulfatase deficiency: a case series. [PDF]

Commun Med (Lond)
Pillai NR, Liu N, Li X, Li X, Ahrens-Nicklas R, Adang L, Eisengart JB, Bronken G, Gupta A, Lund TC, Whitley CB, Elsea SH, Orchard PJ.   +12 more
europepmc   +1 more source

CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologous bone marrow transplantation with 4- hydroperoxycyclophosphamide-purged bone marrow [PDF]

, 1987
SD Rowley, Michael Zuehlsdorf, HG Braine, O. Michael Colvin, Jeffrey Davis, RJ Jones, Rein Saral, LL Sensenbrenner, A. Yeager, GW Santos   +9 more
openalex   +1 more source

Efficacy and Safety of the Third‐Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation

American Journal of Hematology, EarlyView.
Xiaoyu Zhang, Yigeng Cao, Jialin Wei, Weihua Zhai, Qiaoling Ma, Chen Liang, Xin Chen, Wenbin Cao, Donglin Yang, Aiming Pang, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang   +14 more
wiley   +1 more source

B cells and systemic sclerosis interstitial lung disease

Arthritis &Rheumatology, Accepted Article.
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman, Voon Ong, Christopher Denton   +2 more
wiley   +1 more source

Chimerism after whole organ transplantation: an explanation of renal and other organ acceptance [PDF]

, 1997
Demetris, AJ, Murase, N, Rao, AS, Starzl, TE, Thomson, AW, Trucco, M   +5 more
core  

Patients admitted in the intensive care unit after solid organ or bone marrow transplantation: Retrospective cohort study. [PDF]

World J Transplant
Vujaklija Brajkovic A, Kosuta I, Batur L, Sundalic S, Medic M, Vujevic A, Bielen L, Babel J.   +7 more
europepmc   +1 more source